NOVEMBER 2022LIFE SCIENCES REVIEW6Life sciences companies rely on sustained marketing to drive reach, awareness, conversion, and loyalty.In 2022, life sciences companies are seeing enough long-term growth opportunity to feel cautiously optimistic about the remainder of the year and beyond. However, many life science and healthcare organizations are increasingly focused on optimizing operating performance (e.g., addressing complexity and quality in manufacturing, R&D, finance, safety and even marketing) while working within evolving regulatory and risk environments, ongoing pricing and cost pressures on medicines and devices, and the adoption of new business models enabled by scientific advances, such as the maturing of precision medicine and immune therapies.Life sciences companies will need to assess the value of their initiatives from a selling perspective due to cost pressures. Importantly, amid the shift to outcomes-focused, value-based healthcare, life science companies may continue to bear the brunt of public and private payers' efforts to control costs. Truly innovative products that address unmet needs (e.g. hepatitis C and oncology) may continue to command premium prices.The life science brands that will be successful will be those that place people at the center of their brand promise and marketing campaigns. In order to achieve this, those organizations will segment their audiences in a far more sophisticated and detailed way than ever before. These companies will gain an understanding of human needs and desired outcomes--even if they're an enabling technology and not a therapy.An aging U.S. population and a proliferation of chronic diseases will drive continued patient demand for targeted therapies amid reform-driven drug price controls. Life sciences companies will therefore need to find a balance between innovation and efficiency. Additionally, with growing patient and payer resistance, drug and device manufacturers will find themselves increasingly having to make economic arguments in their marketing efforts to defend or gain market share.Let us know your thoughts.EDITORIALThe Evolving World of Life Sciences MarketingCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com NOVEMBER - 17 - 2022, Vol 03, Issue - 33 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz Clara Matthew
< Page 5 | Page 7 >